Federated Hermes’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-37,210
Closed -$2.42M 2332
2021
Q3
$2.42M Sell
37,210
-107,895
-74% -$7.36M ﹤0.01% 987
2021
Q2
$9.2M Sell
145,105
-49,728
-26% -$2.94M 0.02% 685
2021
Q1
$11.7M Buy
+194,833
New +$10.6M 0.02% 621
2020
Q4
Sell
-88,706
Closed -$4.53M 2358
2020
Q3
$4.53M Buy
88,706
+88,621
+104,260% +$3.7M 0.01% 751
2020
Q2
$3K Buy
+85
New +$2.93K ﹤0.01% 2064

Other funds holding AXNX

Federated Hermes's AXNX Position: Q4 2021 in Review

Federated Hermes sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2021, closing a stake of 37,210 shares — an estimated $2.42M sold.

Federated Hermes first reported a position in AXNX in Q2 2020 and held it in 5 quarters. The position peaked at $11.7M in Q1 2021. 180 funds tracked by Wall St. Rank hold AXNX as of Q4 2021.

  • Federated Hermes reported no remaining Axonics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Federated Hermes sold 37,210 Axonics, Inc. Common Stock shares in Q4 2021, an estimated $2.42M.
  • Federated Hermes first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Federated Hermes's Axonics, Inc. Common Stock position peaked at $11.7M in Q1 2021.
  • 180 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2021.

Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.